Imugene has now crossed ethics approval off is list, and the way is now clear for clinical trials to begin in Australia.
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
Biotech immunotherapy company Imugene [ASX:IMU] rose more than 10% on Wednesday after releasing an update about its oncolytic virotherapy candidate.
In today’s Money Morning…the digital revolution…the next digital device…our worst decisions will be only a thought away…and more…
As the name suggests, an adoption curve is the process by which a new technology is taken up by the public at large.
Radio and communications manufacturer Codan [ASX:CDA] is defying the market today. The CDA Share price us up 17.92% at time of writing.
PolyNovo [ASX:PNV] shares are rising today after the biotech stock reported its indicative half-year trading results.